Institutional Ownership
Tscan Therapeutics Inc
CUSIP 89854M101COMTCRXQ1 2026
13D / 13G Filings
42
Schedule 13D/13G on record
Beneficial Filers
16
Distinct reporting persons
Largest Stake
15.0%
Max % of class reported
Institutional Holders
57
13F filers (latest quarter)
Beneficial Owners — Schedule 13D / 13G
42 filings · latest Aug 14, 2025
| # | Filed | Reporting Person | Form | % of Class | Shares | Filing |
|---|---|---|---|---|---|---|
| 1 | Aug 14, 2025 | Lynx1 Capital Management LP | 13G/A | 15.0% | 7.86M | SEC |
| 2 | Aug 12, 2025 | Adage Capital Management, L.P. | 13G/A | 2.5% | 1.35M | SEC |
| 3 | Jul 16, 2025 | Blackrock, Inc. | 13G/A | 1.8% | 958.4K | SEC |
| 4 | May 15, 2025 | Ecor1 Capital, LLC | 13G/A | 1.3% | — | SEC |
| 5 | May 15, 2025 | Biotechnology Value Fund L P | 13G/A | 10.0% | 5.26M | SEC |
| 6 | Apr 24, 2025 | Blackrock, Inc. | 13G/A | 5.4% | 2.83M | SEC |
| 7 | Feb 14, 2025 | K2 Healthventures Equity Trust LLC | 13G/A | 6.9% | 3.60M | SEC |
| 8 | Feb 14, 2025 | Lynx1 Capital Management LP | 13G/A | 10.9% | 5.36M | SEC |
| 9 | Feb 12, 2025 | Adage Capital Management, L.P. | 13G/A | 7.1% | 3.50M | SEC |
| 10 | Nov 14, 2024 | Cormorant Asset Management, LP | 13G/A | — | — | SEC |
32 more beneficial-ownership filings on Premium
See the full Schedule 13D/13G history for Tscan Therapeutics Inc.
Unlock full historyTop Institutional Holders (13F)
Largest reported positions · latest quarter
| # | Fund | Shares | Value |
|---|---|---|---|
| 1 | Lynx1 Capital Management LP | 8.02M | $8.10M |
| 2 | Bvf Inc/Il | 5.56M | $5.62M |
| 3 | Baker Bros. Advisors LP | 2.78M | $2.81M |
| 4 | Blackrock, Inc. | 1.84M | $1.86M |
| 5 | Millennium Management LLC | 1.46M | $1.47M |
| 6 | Renaissance Technologies LLC | 1.36M | $1.38M |
| 7 | Deer Management Co. LLC | 1.25M | $1.26M |
| 8 | Two Sigma Investments, LP | 1.21M | $1.22M |
| 9 | Aberdeen Group PLC | 918.0K | $927.2K |
| 10 | Jacobs Levy Equity Management, Inc | 808.4K | $816.4K |